{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-419174","form_type":"8-K","ticker":"PCVX","cik":"0001649094","company_name":"Vaxcyte, Inc.","filed_at":"2026-10-09T20:42:27+00:00","discovered_at":"2026-10-09T20:43:00.225748+00:00","generated_at":"2026-10-12T15:04:30.195598+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vaxcyte raises ~$1.10B via concurrent offerings: $575M 1.50% converts due 2032 and $64/share stock sale","bullets":["$575M aggregate 1.50% convertible senior notes due Oct 15, 2032; initial conversion price ~$89.60/share (11.1607 shares per $1,000); $75M over-allotment exercised in full.","Equity offering of 7,412,500 shares at $64.00 plus 400,000 pre-funded warrants at $63.999; underwriters' 30-day option for 1,171,875 more shares exercised in full.","Net proceeds ~$544.3M from the equity sale and ~$558.7M from the notes after discounts and expenses; both offerings closed Oct 9, 2026.","Interest on the notes payable semi-annually Apr 15 and Oct 15, starting Apr 15, 2027; provisional redemption permitted on/after Oct 22, 2029 if the stock tops 130% of conversion price.","Jefferies LLC and Leerink Partners LLC led both deals; notes are senior unsecured obligations under an indenture with U.S. Bank Trust Company as trustee."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-419174","json":"https://secwatch.observer/filing/0001193125-26-419174.json","markdown":"https://secwatch.observer/filing/0001193125-26-419174.md","text":"https://secwatch.observer/filing/0001193125-26-419174.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526419174/0001193125-26-419174-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526419174/d150490d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T15:04:30.195598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}